Search results for: Real World Evidence (RWE)
Filter search results
OHE responds to the Trump administration’s Executive Order on Drug Prices
14 May 2025
…Commenting on the Executive Order, Professor Graham Cookson, Chief Executive of the Office of Health Economics, said: “President Trump believes the rest of the world are “free riding” on the US,…
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
4 October 2016, 11:00pm
…real world evidence and advanced therapies); Future developments in HTA scientific advice; Issues specific to outcomes advice. The panel will be chaired by Paula Lorgelly, Deputy Director, OHE, and will…
Prospective Observational Studies: Whether, When and How to Use
18 June 2012
…real-world conditions, will only increase as both public and private payers seek to ensure that the use of medical technologies is as cost-effective as possible. At the same time, however,…
Dr Francois Maignen joins the OHE team as Head of Operational Research and Data Analysis
7 July 2016
…observational or real world evidence after conditional approval), and was involved in the IMI ADAPT-SMART project. Francois has developed and maintained the NICE scientific advice database and he has performed…
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
23 August 2016
…scientific and outcomes advice in the clinical development of medicines; The integration of HTA with regulatory scientific advice; Issues associated with new approaches to drug development (adaptive licensing, real world…
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
…treatments, and enhance their uptake. For example, reduced delays in regulatory approval and national-level access could be facilitated through managed entry agreements and the greater exploitation of real-world evidence. In…
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
…side effects like nausea for faster weight loss. These trade-offs aren’t just clinical – they’re personal and behavioural, and they shape treatment adherence and real-world outcomes. Importantly, treatment preferences among…
Health Care without Frontiers?
1 December 2000
…provide some insight into what motivates patients to move across borders for health care6. In addition to this literature-based evidence, there was also anecdotal evidence that groups representing patient interests…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
…that collects data on drug sales worldwide. IMS data for all outpatient drug sales in 1992 are used to construct price indexes based on all molecules that match across the…